Introduction
To survive, most normal epithelial and endothelial cells require adhesion to a specific type of extracellular matrix called the basement membrane (BM) . Upon loss of cell-BM contacts, these cells undergo apoptosis, a phenomenon now widely known as anoikis (Meredith et al., 1993; Frisch and Francis, 1994; Rak et al., 1995; Frisch and Screaton, 2001; Reed et al., 2004) . Anoikis plays a critical role in several morphogenetic and homeostatic processes (Frisch and Ruoslahti, 1997; Meredith and Schwartz, 1997; Grossmann, 2002) , such as embryo cavitation (Coucouvanis and Martin, 1995) , postweaning mammary gland regression (Strange et al., 1992) , and elimination of epithelial cells shed into the lumen of the intestine (Ikeda et al., 1998) . The interest in studying anoikis increased significantly when it became evident that resistance to anoikis is required for invasion and metastasis in cancers of epithelial origin (Evan and Vousden, 2001; Frisch and Screaton, 2001 ). Thus, a better understanding of the molecular mechanisms involved in anoikis and in cancer-associated anoikis resistance is critical for the development of therapies designed to restore sensitivity to anoikis in malignant cells.
A significant amount of evidence has been accumulated during the last few years indicating that both the mitochondrial and the death receptor pathways play a role in anoikis (Frisch, 1999; Rytomaa et al., 1999 Rytomaa et al., , 2000 Aoudjit and Vuori, 2001; Ishida et al., 2002; Reginato et al., 2003) . In the case of intestinal epithelial cells, and using the IEC-18 cell line from normal rat intestinal epithelium as an experimental model (Quaroni and May, 1980) , our laboratory has shown that cell detachment simultaneously triggers the downregulation of Bcl-xL, an antiapoptotic component of the mitochondrial pathway (Rosen et al., 2000) , and the upregulation of Fas ligand (FasL), an activator of the death receptor pathway . Interestingly, both events occur within minutes after cell detachment (Rosen et al., 2000 , but detached IEC-18 cells do not irreversibly commit to apoptosis for at least 2 h (Krestow et al., 1999) . A similar delay in the commitment to anoikis after the initial proapoptotic events have been triggered by cell detachment has also been observed in mammary epithelial cells (Gilmore et al., 2000; Wang et al., 2003) .
It seems, therefore, that epithelial cells are transiently protected from anoikis immediately after detachment. The molecular mechanisms involved in this protection are not known. Here we report that one of such mechanisms is a transient detachment-triggered increase in the activity of Src-family kinases (SFK). Furthermore, our results suggest that this transient protection from anoikis is at least partly mediated by the PI3K pathway, and the phosphorylation of caveolin-1 in Tyr14. In addition, we show that ERK1/2 acts in a synergistic manner with SFK to protect intestinal epithelial cells from anoikis.
Results
We have previously shown that there is a noticeable downregulation of c-Src kinase activity when IEC-18 intestinal epithelial cells are kept in long-term suspension cultures (Rosen et al., 2001) , and we suggested that this downregulation partly contributes to anoikis in these cells. While studying this phenomenon in more detail, however, we noticed that immediately after cell detachment c-Src activity is transiently upregulated. We then hypothesized that this increase in c-Src activity might be responsible for the transient protection of IEC-18 cells against anoikis. This protection lasts at least 2 h after cell detachment as described in a previous publication (Krestow et al., 1999) . We therefore decided to characterize in further detail the profile of c-Src activity at different time points after cell detachment. A standard in vitro kinase assay (IVKA) showed that the activity of c-Src dramatically increases as early as 5-10 min after cell detachment, and then gradually declines until it reaches, approximately 2 h later, levels comparable to those of monolayer cultures (Figure 1a ). Since the IVKA measures c-Src activity after immunoprecipitation from cell lysates and not in the context of an intact cell, we sought to analyse the transient activation of c-Src by other means. Upon activation, c-Src undergoes transautophosphorylation of its Tyr419 residue, which locks the kinase domain of c-Src in its active conformation (Biscardi et al., 1999) . A Western blot analysis of c-Src immunoprecipitated from IEC-18 lysates obtained at different time points after cell detachment showed a pattern of Tyr419 phosphorylation that is in accordance with the transient increase in c-Src activity seen by the IVKA (Figure 1b ). In addition, we analysed the phosphorylation state of paxillin, a bona fide intracellular c-Src substrate. As shown in Figure 1c , we found that paxillin was also transiently phosphorylated upon detachment of the IEC-18 cells. Finally, and as part of experiments described in further detail below, we also studied the kinetics of caveolin-1 phosphorylation after cell detachment, since caveolin-1 is another well-characterized substrate of c-Src (Li et al., 1996) . The changes in caveolin-1 phosphorylation also followed a pattern in accordance with the transient activation of c-Src suggested by the previous experiments (Figure 7a ). Together, these results demonstrate that detachment of IEC-18 cells triggers a significant but transient increase in c-Src activity, which is followed by a gradual return to its baseline levels approximately 2 h later. This transient activation of c-Src was not due to the trypsinization used for detachment of the cells, since a similar activation was observed in cells that were detached by EDTA (data not shown).
To test our hypothesis that this transient, detachmentinduced upregulation of c-Src activity contributes to the early protection against anoikis observed in IEC-18 cells, we first analysed the effect of PP1, a widely used pharmacological inhibitor of SFK, on anoikis. The experimental design used to test this hypothesis is schematically described in Figure 2a , and it is based on the following premise: if the early increase in c-Src activity truly confers transient protection to anoikis, the inhibition of such activity by PP1 should accelerate cell death, whereas inhibiting c-Src after it has fallen below its monolayer levels should have a much lesser, if any, effect on anoikis. Figure 2b shows that when IEC-18 cells were incubated in suspension for 3 h in the presence of PP1 there is a significant enhancement of anoikis. An identical treatment of IEC-18 cells growing in monolayer culture with PP1 did not affect cell viability, thus ruling out that the effect of PP1 on suspension cultures is due to a general proapoptotic effect of this drug. On the other hand, no anoikis-enhancing effect could be observed if the PP1 treatment was started 4 h after detachment, which corresponds to the approximate time at which c-Src activity falls below its monolayer levels (Rosen et al., 2001) . This result could not be explained by saturation of the apoptotic signal, because cells maintained in suspension in the absence of PP1 for longer periods (9-12 h) showed even higher levels of apoptosis (data not shown).
Next we decided to verify the results obtained with PP1 by inhibiting SFK activity with a kinase defective dominant-negative mutant of c-Src (DK-Src). To avoid effects that may be secondary to a permanent inhibition of SFK activity, we decided to carry out these The filters were then stripped and reprobed for total paxillin levels experiments using a transient transfection approach. Unfortunately, a very low efficiency of transient transfection in IEC-18 cells precludes the use of the apoptosis assays described above. We therefore used an alternative experimental approach schematically described in Figure 2c . Briefly, we cotransfected vectors containing the indicated cDNAs on a 3 : 1 ratio with a GFP expression vector, and compared the proportion of GFP-positive cells after 24 h in monolayer vs suspension culture. The rationale behind this approach is as follows: cells cotransfected with GFP and a cDNA that has no effect on anoikis will die at the same rate as untransfected cells when placed in suspension culture, maintaining the proportion of GFP-positive cells in suspension the same as in attached cells. Contrarily, cells cotransfected with GFP and an anoikis-inducing or -inhibiting gene will die more rapidly or slowly respectively. This, in turn, will lead to the accumulation of a relatively lower or higher proportion of GFPpositive cells in suspension as compared to those in monolayer culture. Bcl-xL, an antiapoptotic member of the Bcl-2 family previously shown by us to significantly protect IEC-18 cells against anoikis (Rosen et al., 2000) , was used as a positive control in this experiment. As shown in Figure 2d , the transient transfection of the kinase-defective mutant of c-Src induces a reduction in the proportion of GFP-positive cells in suspension culture, consistent with a proanoikis effect of this cSrc mutant. Contrarily, the transfection of a constitutively active mutant of c-Src (Y530F-Src) induces an accumulation of GFP-positive cells in suspension, as expected from a protein with antianoikis activity. Collectively, these observations support the hypothesis that the detachment-induced increase in SFK activity transiently protects IEC-18 cells from anoikis.
Next, we sought to characterize the mechanism implicated in the detachment-induced transient activation of c-Src. First, we analysed the effect of cell detachment on the phosphorylation levels of residue Tyr530 in c-Src. Phosphorylated-Tyr530 binds intramolecularly to the SH2 domain of c-Src, which in turn renders the kinase inactive (Frame, 2002) . As shown in Figure 3a , we did not observe any significant differences in the levels of Tyr530 phosphorylation between cells grown in monolayer or suspension culture. Since c-Src can still be activated while phosphorylated in Tyr530 if another tyrosine-phosphorylated protein competes for its binding to the SH2 domain (Young et al., 2001) , we decided to analyse the effect of cell detachment on the tyrosine phosphorylation of Focal Adhesion Kinase (FAK), a protein that has the potential to activate c-Src by competition. We speculated that upon cell detachment, and before it becomes fully dephosphorylated and/or degraded (Grossmann et al., 2001a) , FAK might be transiently available for binding to the SH2 domain Figure 1a and in Rosen et al. (2001) . Note that PP1 (10 mM) was added either at the beginning or after 4 h of suspension culture, that is, approximately the time at which c-Src falls below its baseline level in monolayer culture (horizontal dashed line). (b) IEC-18 cells were cultured in the absence (À) or presence ( þ ) of 10 mM PP1 as indicated in (a). Apoptosis was measured using a commercial Cell Death ELISA kit. Bars represent the average of triplicates (7s.d.). A representative experiment of four is shown. '*' denotes a statistically significant difference between the groups as determined by a two-tailed, unpaired Student's t-test (Po0.05). (c) Diagram depicting the experimental design used in (d). IEC-18 cells were cotransfected with GFP and various cDNAs. After 48 h, the cells were split and placed in monolayer or suspension cultures for an additional 24 h. The proportion of GFP-positive cells was then determined by FACS. (d) Difference in the proportion of GFPpositive cells between suspension and monolayer cultures. For each treatment, the fold-change in the proportion of GFP-positive cells was scored as a percentage relative to monolayer using the formula: (GFP þ suspÀGFP þ mon)/(GFP þ mon) Â 100. The fold-difference observed in cells cotransfected with GFP and vector control was taken as background and subtracted from the differences obtained with all the other cDNAs. Bcl-xL was used as a positive control. Results from three independent experiments were pooled and the graph shows average values7s.d.
of SFK, leading to their activation. Our results, however, did not support this possibility (Figure 3b ). We observed that the levels of tyrosine phosphorylation of FAK decreased immediately after detachment of IEC-18 cells, as did the interaction of FAK with active SFK (detected with an anti-pY419 antibody). This result suggests that FAK is not involved in detachmentinduced c-Src activation in IEC-18 cells.
Since our previous study showed that v-Src-induced resistance to anoikis in IEC-18 cells is partly mediated by the MEK1-ERK1/2 pathway (Loza Coll et al., 2002), we decided to investigate whether this pathway is also involved in mediating the early protection from anoikis conferred by increased c-Src activity. We found that the levels of ERK1/2 phosphorylation in Thr202 and Tyr204, which are indicative of its activation, followed closely the pattern of c-Src activity observed after cell detachment by trypsinization (Figure 4a ) or EDTA treatment (data not shown). We then detached IEC-18 cells in the presence of PP1 to explore if the detachmentinduced activation of ERK1/2 might be a consequence of the activation of SFK. As shown in Figure 4b , we found that SFK contribute only slightly to the induction of ERK1/2 activity triggered by cell detachment. Accordingly, the short-term sensitivity to anoikis of IEC-18 cells treated with PD98059 was notably lower than that of cells treated with PP1 ( Figure 4c ). These results suggest that the MEK1-ERK1/2 pathway makes a very small contribution to the transient protection against anoikis provided by SFK.
Next we investigated the involvement of the PI3K pathway in the transient protection of IEC-18 cells against anoikis. This pathway has been previously shown to mediate the antiapoptotic activity of c-Src in colon cancer cells (Windham et al., 2002) . As shown in Figure 5a , detachment of IEC-18 cells transiently induces PI3K activity, as indicated by the phophorylation of Akt, a downstream effector of PI3K. This activation of PI3K, which could also be observed after EDTA treatment (not shown), was indeed largely inhibited by PP1 (Figure 5b ), suggesting that it was triggered by SFK. In fact, the enhancement of short- To further characterize the signals involved in the transient anoikis protection displayed by IEC-18 cells, we decided to investigate the effect of the simultaneous inhibition of SFK and the MEK1-ERK1/2 or PI3K pathways on anoikis. As shown in Figure 6a , treating cells with PP1 and LY294002 has an additive effect on the anoikis of IEC-18 cells. On the other hand, simultaneous treatment with PP1 and PD98059 had a synergistic effect (Figure 6b ). Given this result, we decided to investigate in greater detail the functional relationship between cell detachment and the activation of SFK and the MEK1-ERK1/2 pathway. Interestingly, although the treatment of suspended cells with PP1 strongly inhibited ERK1/2 phosphorylation shortly after cell detachment (Figure 6c , lane 3), this effect was notably reduced (lane 6), and eventually reverted (lanes 9 and 12) as the cells were incubated with PP1 in The same lysates were also probed for total levels of ERK1/ 2. Third panel: The same lysates were probed for levels of the active fragment of caspase-3 (p17). Fourth panel: A Western blot for CDK4 was used as a loading control suspension for longer periods. These results suggest that cell detachment induces a rapid, SFK-dependent activation of the MEK1-ERK1/2 pathway, which is then followed by SFK-independent mechanisms of MEK1-ERK1/2 activation. In addition, that suspended IEC-18 cells incubated with PP1 for 3-6 h show increased ERK1/2 phosphorylation as compared to untreated controls suggests that the upregulation of c-Src activity leads to the slower induction of some unidentified inhibitor of the MEK1-ERK1/2 pathway. In accordance with the results in Figure 4c , when we compared the anoikis-inducing effects of PD98059 and PP1 by assessing the extent of caspase-3 activation, which we have previously established is associated to the execution of anoikis in IEC-18 cells (Rosen et al., 2001) , we found that PP1 was noticeably more effective at inducing caspase-3 cleavage than PD98059 at all time points after cell detachment, confirming that the MEK1-ERK1/2 pathway makes a small contribution to the protective effect of SFK against anoikis.
Previous observations reported by Lee et al. (2000) and Fiucci et al. (2002) , in combination, suggest that a cSrc-mediated phosphorylation of residue Tyr14 in caveolin-1 might protect cells from anoikis. Caveolin-1 is a scaffolding protein that associates with a large range of signaling molecules in a cell type-specific manner (Okamoto et al., 1998) , and it has been recently proposed that this protein might exert an anti-anoikis effect in a context-dependent manner (Carver et al., 2003) . To test whether tyrosine phosphorylation of caveolin-1 might contribute to the transient protection from anoikis in IEC-18 cells, we first compared the levels of pTyr14-caveolin-1 in cells grown in monolayer or suspension cultures at various time points after detachment. As mentioned above, we found that cell detachment induces a transient phosphorylation of caveolin-1 in Tyr14 with a kinetics that closely resembles the pattern of c-Src activation (Figure 7a ). We observed that treatment of IEC-18 cells grown in suspension culture with PP1 fully inhibited the detachment-induced phosphorylation of Tyr14 in caveolin-1, suggesting that this phosphorylation might indeed be attributable to the action of SFK (Figure 7b) .
As a first step towards the elucidation of the role of caveolin-1 in the c-Src-induced transient resistance to anoikis in IEC-18 cells, we tried to reduce caveolin-1 levels by transfecting an antisense cDNA expression vector. We obtained three independent clones displaying various degrees of inhibition of caveolin-1 expression (Figure 7c ). All these clones were significantly more sensitive to anoikis than vector-transfected controls in short-term suspension cultures (Figure 7d) . Notably, this increased sensitivity to anoikis did not seem to be due to alterations in the levels of c-Src activity induced by cell detachment, as shown by an IVKA and by assessment of ERK 1/2 phosphorylation (Figure 8a) .
We have previously shown that stimulation of the epidermal growth factor receptor (EGFR) by tumor growth factor-a (TGFa) inhibits anoikis of IEC-18 cells in an SFK-dependent manner, and proposed that it is the sustained c-Src activity induced by TGFa in suspended cells what underlies such protection (Rosen et al., 2001) . We decided to investigate therefore whether this effect of TGFa on anoikis is abrogated in the clones with reduced caveolin-1 expression. As shown in Figure 8b , the protection against anoikis by TGFa is significantly reduced in such clones. This result is consistent with an activated EGFR and, by extension, SFK activity, acting upstream of caveolin-1. However, we cannot discard the possibility that caveolin-1 is acting on a parallel pathway that functions in an additive manner to regulate anoikis of IEC-18 cells.
The results of the experiments shown above are in accordance with the hypothesis that phosphorylation of caveolin-1 in Tyr14 partly mediates the c-Src-induced protection from anoikis. However, none of these experiments tested this directly. To specifically determine whether phosphorylation of caveolin-1 in Tyr14 indeed mediates the protective effect of the c-Src activity induced by cell detachment, we made use of a dominantnegative Y14N caveolin-1 point mutant. We first tried to stably transfect IEC-18 cells with an Y14N dominantnegative point mutant of caveolin-1 but, unfortunately, we could not obtain any stable clone, possibly because this mutant is highly deleterious for the cells. We decided, therefore, to use the same experimental approach based on transient transfections as in Figure  2c , d. Bcl-xL and the natural SFK inhibitor C-terminal Src Kinase (CSK) were used as controls. When IEC-18 cells were cotransfected with GFP and the Y14N caveolin-1 mutant, there was a significant decrease in the proportion of GFP-positive cells in suspension culture, similar to what was observed with CSK ( Figure 8c ). On the other hand, when GFP was cotransfected with wild-type caveolin-1, even though there was some enhancement of anoikis, it was clearly less than that induced by Y14N-caveolin-1. In order to explore whether these results could be explained by differences in the levels of expression of both constructs, we transiently transfected HEK293-T cells and measured their expression by Western blot, which showed that both cDNAs are expressed to comparable levels (data not shown). These results suggest that a mutant of caveolin-1 that cannot be phosphorylated in Tyr14 induces anoikis in IEC-18 cells, and lend support to the hypothesis that the protective effect of the transient activation of c-Src is, at least in part, transduced by phosphorylation of caveolin-1 in Tyr14.
Since PP1 is an inhibitor of all SFK, and the kinasedefective mutant of c-Src could, in principle, sequester away substrates from other family members, we cannot definitely say that c-Src is the only member of the SFK that is responsible for the transient protection against anoikis in IEC-18 cells. We decided therefore to explore the possible involvement of two other SFK members that are expressed in IEC-18 cells: c-Fyn and c-Yes. Figure 9a shows that c-Fyn activity is also transiently induced by cell detachment, as indicated by the phosphorylation of its Tyr419. This result suggests that, in principle, c-Fyn could also be involved in the protection against anoikis in the IEC-18 cells. On the other hand, we have not been able to immunoprecipitate Yes from IEC-18 cells grown in suspension culture. This is probably due to the fact that detachment of these cells induces a very rapid and sustained decrease in the amount of c-Yes (Figure 9b ). This downregulation of cYes would be inconsistent with a role for this kinase in the transient protection against anoikis of IEC-18 cells, although our inability to immuprecipitate this kinase did not allow us to directly test this hypothesis.
Finally, we sought to determine whether a detachment-induced activation of c-Src could be observed in another intestinal epithelial cell line. Figure 9c shows that c-Src activity, as measured by the IVKA, is transiently increased upon detachment in immortalized mouse colonocytes. We also measured c-Src activity after detachment of two cell lines of endothelial origin, EOMA and SVR, and observed a very similar profile of transient c-Src activation immediately after cell detachment (Figure 9d ). Taken together, these results indicate that the detachment-induced transient activation of cSrc activity is not restricted to the IEC-18 cells. Figure 3d . Bcl-xL and CSK cDNAs were used as controls. Results from three independent experiments were pooled and the graph shows average values (7s.e.)
Discussion
In this paper, we present evidence indicating that detachment of the nonmalignant IEC-18 intestinal epithelial cells triggers a transient, yet significant increase in the activity of the SFK c-Src and c-Fyn, and that the activation of SFK contributes, at least in part, to the transient protection against anoikis that has been observed in these cells. That detachment of IEC-18 cells induces a transient activation of c-Src is supported by several complementary experimental approaches. First, we used an IVKA to measure changes in c-Src activity in response to cell detachment. We also demonstrated that the changes in c-Src activity occur in the context of an intact cell. To this end, we first showed that the profile of phosphorylation of Tyr419 displayed by c-Src in response to cell detachment correlates closely with its kinase activity as measured by the IVKA. Second, we showed a detachment-induced increase in the phosphorylation of paxillin and caveolin-1, two bona fide substrates of SFK. In the case of caveolin-1, this phosphorylation was shown to be sensitive to PP1 treatment, which lends further support to our finding that cell-detachment induces a transient activation of c-Src activity.
In the case of c-Fyn, cell detachment induced a similar profile of activation than that observed for c-Src, suggesting a possible redundant role of these two SFK in transient anoikis protection. Further studies will be required to directly test the involvement of this SFK in the transient protection against anoikis of IEC-18 cells.
It is important to note that a cell detachment-induced increase in c-Src activity has been reported in two previous studies (Maher, 2000; Lin et al., 2004) . However, neither of them described this phenomenon in normal epithelial cells, characterized the changes in the behavior of c-Src in more prolonged suspension cultures, or analysed its effects on cell viability. To our knowledge, the present study is the first to address specifically the physiological role of endogenous c-Src during the normal course of anoikis in nonmalignant epithelial cells.
Technical limitations make it difficult to assess changes in c-Src activity in vivo. However, that we have observed a similar transient activation of c-Src in all the cell lines we analysed, and that similar observations have been made by others (Maher, 2000; Lin et al., 2004) suggest that activation of SFK may be a fairly general phenomenon triggered by cell detachment.
Our results provide a model to explain previous observations regarding the transient protection against anoikis in normal epithelial cells (Krestow et al., 1999; Gilmore et al., 2000) . In fact, experimental evidence exists to propose that various cell types in the organism are very sensitive to detachment (Grossmann et al., 2001b) . Therefore, it is reasonable to expect that molecular tools have evolved to protect normal cells against brief, transient detachments from the BM which are required for some physiological processes, such as cytokinesis of dividing cells. In this regard, it is important to note that a transient activation of c-Src has been shown to correlate with the rounding up of proliferating cells (Zheng and Shalloway, 2001; Zheng et al., 2002) . It is believed that such transient activation of c-Src is related to the cytoskeletal movements underlying cell division. However, our results suggest that such activation may also protect the dividing cells from the proapoptotic events triggered by transient detachment.
As explained above, the phosphorylation of Tyr530 has an inhibitory effect on c-Src activity (Frame, 2002) . We could not show any evidence to support a change in the phosphorylation state of Tyr530 as the basis for the upregulation of c-Src activity triggered by cell detachment. This apparent lack of involvement of Tyr530 phophorylation has also been observed by Lin et al. (2004) using SP-1 mammary carcinoma cells. We therefore investigated the possibility that some other tyr- osine-phosphorylated protein might compete with the C-terminal inhibitory tyrosine for its binding to the SH2 domain and thus activate c-Src (Young et al., 2001; Frame, 2002) . It has been for long known that upon reattachment of cells to the substratum, there is a rapid and very significant increase in c-Src activity, followed by a slow decrease towards a steady state in monolayer (Schlaepfer et al., 1994) . This profile of c-Src activity is strikingly similar to what it is observed upon cell detachment. We thus hypothesized that there might be a common set of molecular events that are triggered during detachment and reattachment of cells to the substratum. A key molecule that is phosphorylated upon cell reattachment and that is known to activate SFK by competition for its SH2 domain is FAK (Inoue et al., 2003) . We therefore investigated whether, in a similar manner, FAK might transiently interact with cSrc leading to its activation immediately after detachment of the cells. However, no such detachment-induced increase in FAK binding to SFK consistent with this hypothesis could be observed.
An alternative explanation for the apparent lack of change in Tyr530 phosphorylation levels is that it occurs in a very small proportion of c-Src molecules within the cell. There is at least one reported precedent for this possibility: Obergfell et al. (2002) detected changes in the phosphorylation state of Tyr530 only in a specific subpopulation of c-Src molecules bound to integrins, but they could not detect them in whole cell c-Srcimmunoprecipitates. Since we do not know which subpopulation of c-Src molecules might be activated by detachment the IEC-18 cells, we are currently unable to analyse this possibility directly.
We found that inhibiting PI3K strongly induces anoikis in IEC-18 cells. As treating the cells with PP1 largely abolished the detachment-induced activation of PI3K, we hypothesized that the PI3K is a major downstream mediator in the protection conferred by SFK. However, when combined, PP1 and LY294002 had an additive effect in inducing apoptosis. We believe that this result is not inconsistent with our hypothesis because the inhibition of PI3K by LY294002 treatment is greater than that induced by PP1 (Figure 5b) . Thus, the fact that LY294002 acts in an additive manner with PP1 in the induction of anoikis most likely reflects an increased inhibition of PI3K. Conversely, that PP1 increases the anoikis-inducing effect of LY294002 likely reflects the fact that c-Src can exert antiapoptotic activity by PI3K-independent pathways.
We have also shown that even though the MEK1-ERK1/2 pathway only partly contributes to the protection against anoikis conferred by SFK, there is a synergistic induction of anoikis when IEC-18 cells are simultaneously treated with PP1 and the MEK inhibitor PD98059. We believe that a likely explanation for this observation is that SFK and the MEK1-ERK1/2 pathway share common downstream antiapoptotic effectors, giving rise to some degree of redundancy between these two pathways. Thus, the limited anoikisinducing effect of PD98059 would be explained by the capacity of SFK signaling to rescue the MEK1-ERK1/2 deficiency at some downstream step of the pathway. On the other hand, and as shown by our results in Figure 6c , while PP1 induces a strong inhibition of ERK1/2 activation early on, it also induces a later accumulation of phosphorylated ERK1/2, possibly because of the inhibitory effect of SFK activity on some unidentified negative regulator of the MEK1-ERK1/2 pathway. This later accumulation of activated ERK might compensate for the decrease in SFK activity. Thus, only the combined use of PP1 and PD98059 would fully abolish the presumptive antiapoptotic effects that SFK and the MEK1-ERK1/2 pathway redundantly activate, generating the observed synergy.
Others have shown that MEK1 induces resistance to anoikis in diverse cell lines including, most notably, colon cancer cell lines (Fukazawa et al., 2002; Weng et al., 2002) . In other cases, however, MEK1 signaling is activated by detachment, but confers only a weak protection against anoikis (Ishida et al., 2002) . In fact, that seems to be the case in our system, based on the comparatively low caspase-3 activation upon treatment of the suspended cells with PD98059. These data suggest that, while the activation of the MEK1-ERK1/2 pathway upon detachment may be a relatively universal phenomenon, its effect on protecting the cells against anoikis is quite cell-specific.
We became interested in the possibility that caveolin-1 mediates the c-Src-induced protection against anoikis of IEC-18 cells based on two recent reports. In one of them Lee et al. (2000) showed that cotransfection of 293T cells with wild-type caveolin-1 and c-Src induced a two fold increase in the number of colonies in a soft agar colony formation assay, an effect that was completely abrogated when c-Src was cotransfected with the Y14N point mutant of caveolin-1. Because the soft-agar colony formation assay does not distinguish between survival in suspension and anchorage-independent growth, these results do not necessarily indicate that the phosphorylation of caveolin-1 by c-Src is conferring resistance to anoikis. A study by Fiucci et al. (2002) , on the other hand, showed that stable transfection of caveolin-1 into MCF-7 cells inhibited anoikis. However, this study did not analyse the involvement of caveolin-1 Tyr14 phosphorylation in this protection. We then decided to explore directly the possibility that a c-Src-mediated phosphorylation of caveolin-1 in Tyr14 might induce the transient resistance to anoikis in IEC-18 cells. Our results in Figure 8c provide experimental evidence indicating that the phosphorylation of caveolin-1 in Tyr14 plays a role in the transient anti-anoikis signal triggered after detachment, and the inhibitory effect of PP1 strongly suggests that SFK are involved in such phosphorylation (Figure 7b ). It should be noted, however, that PP1 could, in principle, inhibit kinases other than SFK (Bain et al., 2003) .
Surprisingly, when IEC-18 cells were transfected with wild-type caveolin-1, there was a slight induction of anoikis, which disagrees with the report by Fiucci et al. (2002) . We believe this might be related to the different constitutive c-Src activity levels in IEC-18 and MCF-7 cells, the latter being thought to be abnormally elevated (Ottenhoff-Kalff et al., 1992) . Based on our hypothesis, overexpressed caveolin-1 would become more easily phosphorylated in Tyr14 in MCF-7 cells, and would constitute therefore a more permanent rather than just a transient source of anti-anoikis signaling. Although caveolin-1 is still largely regarded as a protein with tumor-suppressor function, it has been recently observed that caveolin-1 overexpression is sometimes associated with certain types of highly metastatic tumors, and it has been proposed that an anoikisinhibiting effect of caveolin-1 in these malignant cells might explain such association (Carver et al., 2003) . In that regard, our present findings provide a possible mechanism that could explain the tumor-specific role of caveolin-1, and, most importantly, a new framework for future investigations on the role of caveolin-1 in malignant progression.
Materials and methods

Cell culture
The intestinal epithelial cell line IEC-18 was obtained from Dr A Quaroni (Cornell University, USA); the v-Src/IEC-18 cells were derived by transfection of IEC-18 cells with a v-Src expression vector, and have been described elsewhere (Jamal et al., 1994; Loza Coll et al., 2002) . Immortalized mouse colonocytes were derived from p53-deficient mice (Sevignani et al., 1998) , and were obtained from Dr B Calabretta (Jefferson Medical College, USA). Both the EOMA hemangioendothelioma cell line and the SV-40-immortalized SVR endothelial cell line were obtained from Dr D Dumont (University of Toronto, Canada).
IEC-18 cells and mouse colonocytes were cultured in a-MEM (GIBCO) supplemented with 1 Â GPS (0.3 mg/ml Lglutamine, 100 U/ml penicillin, 100 mg/ml streptomycin -GIBCO), 5% fetal bovine serum (FBS), 10 mg/ml insulin and 0.5% glucose. The EOMA and SVR cells were cultured in DMEM (GIBCO) supplemented with GPS and 10% FBS. For suspension cultures, cells were trypsinized, resuspended in regular culture media and plated over an approximately 1 mm thick layer of 1% sea plaque-agarose polymerized in a-MEM or DMEM plus GPS; or collected after a 5-min incubation in 5 mM EDTA-PBS, gently centrifuged (1000 r.p.m., 3 min) and replated over agarose as before.
Western blotting
Cells were lysed for 30 min on ice in lysis buffer (50 mM TrisHCl (pH 8.0), 120 mM NaCl, 10 mM EDTA, 200 mM NaF, 1 mM Na 3 VO 4 , 0.5% Nonidet P-40, 1 mM phenylmethylsulfonyl fluoride, 50 mg/ml aprotinin, and 10 mg/ml leupeptin). Standard Western blotting protocols were used for all immunoblots throughout this work. Protein samples were subjected to SDS-PAGE of various concentrations (8% for FAK and Src immunoprecipitations, 15% for caspase-3, and 10% for all other Western blots). For washings, blockings and incubations with primary and secondary antibodies we used TBS-T buffer (125 mM Tris-HCl (pH 8.0), 625 mM NaCl, 0.5% Tween 20), supplemented with 5% milk (blockings and secondary antibodies), 5% BSA (primary antibodies) or 2% BSA (blocking and secondary antibody for phospho-Tyrosine blots). All incubations with primary antibodies were performed overnight at 41C. Binding of the antibodies was 
Immunoprecipitations
An amount of 1 mg/ml of antibody was used for all immunoprecipitations. The antibodies were preincubated for 1 h at 41C with a 30 ml/sample of a 50% protein G-sepharose bead slurry (SIGMA), with occasional agitation by flicking. This mixture was then added to the cell lysates, and incubated for 2 h at 41C. The protein G-beads were spun down by centrifugation, washed in lysis buffer (3 Â 500 ml), and boiled for 5 min in 25-30 ml of 2 Â SDS-PAGE loading buffer.
c-Src in vitro kinase assay (IVKA)
The protocol for the c-Src IVKA used in this study is identical to the one described in a previous publication (Rosen et al., 2001) .
cDNA constructs
The cDNA for human wild-type Caveolin-1 was obtained from ATCC and subcloned into the pcDNA3.1 þ /À expression vectors (Invitrogen), both in the sense and antisense orientations. The cDNA for the Caveolin-1Y14N point mutant was cloned in the pcDNA3.1 þ vector, and was a kind gift from Dr T Fujimoto (Nagoya University, Japan). The Bcl-xL expression vector was previously described (Rosen et al., 2000) . For GFP expression, the pEGFP-C1 vector (Clontech) was used. The cDNA for CSK was cloned into the pBOS expression vector and was a kind gift from Dr Alitalo (University of Helsinki, Finland). Both the kinase-deficient (DK) and constitutive (Y530F) c-Src mutants are cloned into the pcDNA3 vector, and were kind gifts from Dr Sherry Botkin (University of Virginia, VA, USA) and Dr. David Shalloway (Cornell University, USA) respectively.
Gene transfection protocols
For the transient GFP cotransfection experiments, 2.5 Â 10 5.
IEC-18 cells were plated in 60 mm tissue culture dishes. After 1 day, 1 mg of pEGFP-C1 was mixed with 3 mg of each cDNA of interest in 250 ml of OPTI-MEM (GIBCO). The cDNAs were incubated at room temperature for 5 min and then mixed with 8 ml of Superfect (QIAGEN). The mix was further incubated at room temperature for 10 min with occasional vortexing, and then added to the cells in 2 ml of a-MEM. After incubation for 3 h at 371C, the medium was replaced withy fresh a-MEM, and cells were cultured for 36-48 h. The cells were then trypsinized and placed in suspension culture or replated as monolayers in 35 mm tissue culture dishes for an additional 24 h, after which the cells were analysed by flow cytometry (see below).
Flow cytometry
Cells were collected by trypsinization at 371C for 5-10 min, washed once in 0.5%. BSA-PBS, gently centrifuged and resuspended in 2.5% BSA, 2.5 mM EDTA-PBS. The cell suspension was then filtered through a 40-mm nylon mesh, and the filtrates were analysed for GFP expression using a FACScalibur station.
Apoptosis assay
Apoptosis levels were determined using a Cell Death ELISA Kit (Roche Molecular Biochemicals), which detects the presence of nucleosomes in the cytoplasm of apoptotic cells.
Other reagents
The MEK1 inhibitor PD98059, the Src family kinase inhibitor PP1, the JNK/p38 SAPK inhibitor SB203580 and the PI3K inhibitor LY 294002 are all from BIOMOL, and recombinant TGFa was obtained from ID Labs.
